The rapid pathogen detection in USA market is expected to increase by USD 178 百万, 年複合成長率で (CAGR) の 6.8% から 2022 に 2028, according to the latest edition of the Rapid Pathogen Detection Market in USA Report.

This industry report offers market estimates of the USA market, その後、製品の詳細な分析が行われます, and testing method. The USA market data on rapid pathogen detection can be segmented by product: detection devices, センサー. 研究によると, the detection devices segment had the largest share in the rapid pathogen detection market in USA. Rapid pathogen detection market is further segmented by testing method: immunological analysis, 質量分析, polymerase chain reaction (PCR). の 2021, the immunological analysis segment made up the largest share of revenue generated by the rapid pathogen detection market.

The detection device market is further segmented into handheld, installed, ポータブル, tabletop. Gen Consulting Company research indicates that the handheld segment occupied the largest share of this market in 2021 今後数年間で最も高い需要が見込まれる.

The USA rapid pathogen detection market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players ANP Technologies Inc., Battelle, Bavarian Nordic A/S, bioMérieux Inc., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, GlaxoSmithKline plc (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, メルクKGaA, Novavax Inc., Soligenix Inc., サーモフィッシャーサイエンティフィック株式会社.

データ中心のレポートは市場動向に焦点を当てています, セグメントの現状と見通し. さまざまな市場セグメントにわたる市場を包括的にカバー, レポートは既存のプレイヤーにとって貴重な資産です, 新規参入者と将来の投資家.

このレポートを購入する理由?
– Get a detailed picture of the USA Rapid Pathogen Detection Market
– Identify segments/areas to invest in over the forecast period in the USA Rapid Pathogen Detection Market
– 競争環境を理解する, 市場の主要企業
– Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
– 3ヶ月間の戦略コンサルティングとリサーチサポート.
– シングルユーザーライセンスに提供される印刷認証.